Transgender Men's Perspectives on HIV Risk and HIV Prevention Interventions

Sponsor
Northwestern University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05666102
Collaborator
(none)
30
1
1
5.9
5.1

Study Details

Study Description

Brief Summary

The goal of this pilot study is to gather and analyze qualitative data from focus groups with Transgender men who have sex with men (TMSM) to learn more about the life experiences unique to TMSM that influence their attitudes and beliefs about HIV risk, as well as to better understand the intersections of these specific sexual and gender identities.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Transgender men's perspectives on HIV risk and HIV prevention interventions
N/A

Detailed Description

Men who have sex with men (MSM) are disproportionately impacted by HIV in the United States. While most new HIV infections are assumed to occur between cisgender men who have sex with other cisgender men, an increasing body of literature proposes that transgender men and transmasculine people who have sex with cisgender men (TMSM) might be at elevated risk for HIV infection. Despite data suggesting that transgender men and cisgender men are regularly engaging in sexual relationships, the majority of research on HIV among MSM focuses almost exclusively on sexual partnerships between cisgender gay and bisexual men. Additionally, when HIV prevention research does include transgender people, it almost exclusively focuses on HIV risk within transgender women and transfeminine people. TMSM are rarely mentioned as potential sexual partners for cisgender men and have historically been left out of most research on HIV prevention and in preventive intervention development. The goal of this pilot study is to gather and analyze qualitative data from focus groups with TMSM to learn more about the life experiences unique to TMSM influence their attitudes and beliefs about HIV risk, as well as to better understand the intersections of these specific sexual and gender identities. The investigators will enroll 30 TMSM in 5 focus groups where they will examine the unique contexts in which risk for HIV acquisition occurs for TMSM, and explore participant preferences for HIV prevention services. Focus group questions will focus on five areas: 1) Gathering information related to partner selection and sorting among TMSM; 2) assessing TMSM's perceptions of HIV risk in their lived experiences; 3) exploring the various types of sexual behavior TMSM are engaging in; 4) understanding the various HIV prevention strategies currently being deployed by TMSM; and 5) examine the preferences TMSM have for receiving information related to sexual health and HIV prevention information. Focus group guide content areas may be updated in subsequent groups to reflect additional topics that may emerge from conversations in prior focus groups. Data from the groups will be analyzed by the investigator and study team using an iterative, thematic process. These themes will be synthesized in the development of culturally relevant HIV prevention interventions for TMSM.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Transgender Men's Perspectives on HIV Risk and HIV Prevention
Actual Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
Mar 30, 2023
Anticipated Study Completion Date :
Apr 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Focus Groups

Focus groups will occur during the course of the study period.

Behavioral: Transgender men's perspectives on HIV risk and HIV prevention interventions
Investigators will enroll 30 TMSM in 5 focus groups where they will examine the unique contexts in which risk for HIV acquisition occurs for TMSM, and explore participant preferences for HIV prevention services. Focus group questions will focus on five areas: 1) Gathering information related to partner selection and sorting among TMSM; 2) assessing TMSM's perceptions of HIV risk in their lived experiences; 3) exploring the various types of sexual behavior TMSM are engaging in; 4) understanding the various HIV prevention strategies currently being deployed by TMSM; and 5) examine the preferences TMSM have for receiving information related to sexual health and HIV prevention information.

Outcome Measures

Primary Outcome Measures

  1. Post-hoc thematic analysis across five domains [up to 9 months]

    Post-focus group thematic analysis of attitudes and preferences of HIV prevention messaging and strategies for transgender men and transmasculine people in five separate domains: Partner selection and sorting among trans men who have sex with cis men (TMSM); TMSM's perceptions of HIV risk in their lived experiences; Exploring the various types of sexual behavior TMSM are engaging in; Understanding HIV prevention strategies currently used by TMSM; and Examine the preferences TMSM have for receiving information related to sexual health and HIV prevention.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18+; living in the United States;

  • Assigned female at birth;

  • Current gender identity of trans man or transmasculine;

  • Sexual orientation of NOT heterosexual;

  • Has access to the Internet.

Exclusion Criteria:
  • Under 18;

  • Living outside of the US;

  • Assigned male at birth;

  • Current gender identity OUTSIDE of transgender man or transmasculine person;

  • Heterosexual/straight;

  • Does not have access to the Internet.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institute for Sexual and Gender Minority Health and Wellbeing Chicago Illinois United States 60611

Sponsors and Collaborators

  • Northwestern University

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Ricky Hill, Research Assistant Professor, Northwestern University
ClinicalTrials.gov Identifier:
NCT05666102
Other Study ID Numbers:
  • STU00217158
First Posted:
Dec 27, 2022
Last Update Posted:
Dec 27, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ricky Hill, Research Assistant Professor, Northwestern University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 27, 2022